Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Strides Pharma, Inc.

Strides Pharma, Inc. Recalls

All product recalls associated with Strides Pharma, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jul 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–12 of 12 recalls

Cinacalcet Tablets 90mg (Strides Pharma) – Failed Dissolution (2025)

Failed Dissolution Specifications.

Class IIModerate

FDAJul 9, 2025Nationwide• Strides Pharma, Inc.

Testosterone Gel (Strides Pharma) – Benzene Presence (2025)

Presence of foreign substance: Presence of Benzene.

Class IIModerate

FDAMar 5, 2025Nationwide• Strides Pharma, Inc.

Testosterone Gel (Strides Pharma) – Benzene Presence (2025)

Presence of foreign substance: Presence of Benzene.

Class IIModerate

FDA

Mar 5, 2025

Nationwide

• Strides Pharma, Inc.

Methoxsalen Capsules (Strides) – Failed Dissolution (2023)

Failed Dissolution Specifications

Class IIModerate

FDADec 29, 2023Nationwide• Strides Pharma Inc.

Losartan Tablets (Strides) – Foreign Substance (2023)

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Class IIModerate

FDAJun 26, 2023Nationwide• Strides Pharma Inc.

Prednisone Tablets (Strides Pharma) – Foreign Tablet Contamination (2022)

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Class IIModerate

FDAJul 19, 2022Nationwide• Strides Pharma Inc.

Losartan Potassium Tablets (Strides) – CGMP Deviation (2022)

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Class IIModerate

FDAMay 18, 2022Nationwide• Strides Pharma Inc.

Losartan Potassium Tablets (Strides) – CGMP Deviation (2022)

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Class IIModerate

FDAMay 18, 2022Nationwide• Strides Pharma Inc.

Losartan Potassium Tablets (Strides Pharma) – CGMP Impurity Deviation (2022)

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Class IIModerate

FDAMay 18, 2022Nationwide• Strides Pharma Inc.

Potassium Chloride Extended-Release Tablets (Strides) – Dissolution Failed (2021)

Failed Dissolution Specifications

Class IIModerate

FDASep 27, 2021Nationwide• Strides Pharma Inc.

Tacrolimus Capsules (Strides) – Moisture Limit Failure (2020)

Failed Moisture Limits

Class IIILow

FDADec 22, 2020PA• Strides Pharma Inc.

Benzonatate Capsules (Strides) – Preservative Content Issue (2017)

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Class IIILow

FDAMay 9, 2017Nationwide• Strides Pharma INC